FUNDAMENTALS
EdgeFII/DII
KIMSKrishna Inst Of MED SCI L
₹795.60+3.62%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
KIMSNSE · EquityHealthcare Services

Krishna Inst Of MED SCI L

ISIN
INE967H01025
Instrument key
NSE_EQ|INE967H01025
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹795.60+27.80 · +3.62%
Day rangecircuit ₹636.50 – ₹954.70
760.70
801.50

as of 21/11/2026, 1:24:49 pm

Open
₹764.35
Day high
₹801.50
Day low
₹760.70
Prev. close
₹767.80
Volume
10.44 L
VWAP
₹789.81

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 month · 30-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M
6M
1Y
5Y
MAX
Change · 1M
+18.94%
665.90 → 792.00
Period high
₹801.50
20/11/2026
Period low
₹655.05
22/10/2026
From high
-1.19%
+20.91% from low
Avg volume
35.0K
96.60 L total
Candles
276
153 up / 120 down
20 Nov 2026O 796.80H 797.95L 789.05C 792.00Vol 96.1K
SMA 20SMA 50Averages need 50 candles before they begin
Candle data276 rows of open, high, low, close and volumeShowHide
20 Nov 2026796.80797.95789.05792.00-0.60%8.9096.1K
20 Nov 2026788.95801.50787.55796.80+0.99%13.951.55 L
20 Nov 2026789.25790.80787.70788.75-0.06%3.1059.8K
20 Nov 2026789.75790.10788.00788.85-0.11%2.1053.0K
20 Nov 2026788.45791.30787.95789.35+0.11%3.3553.5K
20 Nov 2026793.90794.95788.25788.45-0.69%6.7043.6K
20 Nov 2026794.35797.15793.60793.90-0.06%3.5533.3K
20 Nov 2026788.70795.60787.00794.35+0.72%8.602.74 L
20 Nov 2026787.30790.50780.00788.15+0.11%10.5045.8K
20 Nov 2026781.75788.55781.35787.40+0.72%7.2032.1K

Historical price and volume data · Showing 1–10 of 276

1 / 28

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

169.98
Company
169.98
Sector
55.28

Worse than sector by 207%

P/B

Price ÷ book value per share

8.52
Company
8.52
Sector
3.05

Worse than sector by 179%

ROA

Net income ÷ total assets

2.21%
Company
2.21%
Sector
4.2%

Worse than sector by 47%

ROE

Net income ÷ shareholders' equity

5.4%
Company
5.4%
Sector
-31.98%

Better than sector by 117%

ROCE

EBIT ÷ capital employed

7.29%
Company
7.29%
Sector
11.89%

Worse than sector by 39%

Quick Ratio

Liquid assets ÷ current liabilities

0.68
Company
0.68
Sector
32.98

Worse than sector by 98%

EV/EBITDA

Enterprise value ÷ EBITDA

37.8
Company
37.8
Sector
23.22

Worse than sector by 63%

04/Business

About the company

Sector: Healthcare Services

Krishna Institute of Medical Sciences Ltd is an India-based company, which is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Company’s institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.

Sector market cap (INR)
₹33,483 Cr

reported in crore

Sector market cap (USD)
$3.72B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹3,931 Cr
+28.17% vs Mar 2025
Net profit · Mar 2026
₹242 Cr
-41.62% vs Mar 2025
Operating margin
8.5%
was 18.2%
Revenue CAGR · 4p
20.9%
profit -12.9% · op -11.7%
Filed order
Revenue3,9313,0672,5142,224
Revenue growthreported28.2%22.0%13.1%—
Operating profit334558460485
Operating profit growthreported-40.1%21.4%-5.2%—
Operating marginderived8.5%18.2%18.3%21.8%
Net profit242415336366
Net profit growthreported-41.6%23.4%-8.2%—
Net marginderived6.2%13.5%13.4%16.5%
EPS — basic₹/share, annual6.039.617.7542.03

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹7,759 Cr
+35.26% YoY
Total liabilities
₹5,200 Cr
Net worth
₹2,559 Cr
Liabilities ÷ assets
67.0%
lower means a lighter balance sheet
Filed order
Total assets7,7595,7363,8522,941
Total liabilities5,2003,3171,7591,003
Net worthderived2,5592,4192,0931,938
Liabilities ÷ assetsderived67.0%57.8%45.7%34.1%
Asset growthderived35.3%48.9%31.0%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets6,8215,0393,3042,464
Current Assets937697547478
Total Assets7,7595,7363,8522,941
Current Liabilities1,239836452296
Net Current Asset-301-13995181
Non-Current Liabilities3,9612,4811,307707
Equity Capital2,5592,4192,0931,938
Total Equity & Liabilities7,7595,7363,8522,941

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹511 Cr
-12.20% YoY
Investing
-₹1,452 Cr
Financing
₹940 Cr
Free cash flow
-₹941 Cr
operating + investing
Filed order
Operating activities511582521432
Operating changereported-12.2%11.7%20.6%—
Investing activities-1,452-1,116-753-547
Investing changereported-30.1%-48.3%-37.6%—
Financing activities94054321720
Financing changereported73.1%150.6%1003.7%—
Net cash flowderived-19-15-95
Free cash flowoperating + investing-941-534-231-115

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax334558460485
Income before WC changes812800646599
Change in Assets-248-139-35-28
Change in Liabilities976250-41
Change in WC-150-7715-69
Cash flow from Operations511582521432
Cash flow from Investing-1,452-1,116-753-547
Cash flow from Financing94054321720
Total Cash Flow-19-15-95
Cash (Start of the year)56476226
Cash (End of the year)55564762

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
32.66%
+0.16 pts QoQ
FII
15.01%
+0.27 pts QoQ
DII (other)
4.09%
-1.82 pts QoQ
Mutual funds
28.21%
-0.31 pts QoQ
Retail & others
20.03%
+1.70 pts QoQ
Filed order
Promoters32.7%32.5%34.1%34.1%
FII15.0%14.7%14.6%14.3%
DII (other)4.1%5.9%5.1%5.2%
Mutual funds28.2%28.5%27.4%27.5%
Retail & others20.0%18.3%18.8%18.9%
Promoters — QoQ changepts, derived0.2%-1.6%0.0%—
FII — QoQ changepts, derived0.3%0.2%0.2%—
DII (other) — QoQ changepts, derived-1.8%0.8%-0.1%—
Mutual funds — QoQ changepts, derived-0.3%1.1%-0.1%—
Retail & others — QoQ changepts, derived1.7%-0.5%-0.0%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

5102050
  • Thumbnail: Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?
    yesterday20/11/2026, 11:17:17 am
    Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?

    Healthcare stocks like Apollo Hospitals and Max Healthcare, among others, were witnessing buying momentum in an overall volatile market on Friday, November 20, as investors focused on the constructive outlook despite the selling pressure from the global markets.

Showing 1–1 of 1 article

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue3,9053,0352,4982,198
Other Income26321626
Total Revenue3,9313,0672,5142,224
Total Expenses3,5882,5202,0551,753
Profit Before Tax334558460485
Tax92143124119
Profit After Tax242415336366
EPS - Basic6.039.617.7542.03
EPS - Diluted6.039.617.7542.03

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.